These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Low molecular weight dextran in systemic sclerosis and Raynaud's phenomenon. Dodman B; Rowell NR Acta Derm Venereol; 1982; 62(5):440-2. PubMed ID: 6183899 [No Abstract] [Full Text] [Related]
10. Failure of low molecular weight dextran infusions in scleroderma. Kirk JA; Dixon AS Ann Rheum Dis; 1969 Jan; 28(1):49-54. PubMed ID: 5786283 [No Abstract] [Full Text] [Related]
11. [Treatment of progressive scleroderma using carnitine]. Schneider D Z Gesamte Inn Med; 1974 Jul; 29(13):544-9. PubMed ID: 4281970 [No Abstract] [Full Text] [Related]
16. [Personal experience with low molecular weight dextran, "Rheomacrodex", in the treatment of acute vascular obstructions]. Fabra Jiménez L Rev Esp Cardiol; 1966 Apr; 19(2):189-97. PubMed ID: 5945474 [No Abstract] [Full Text] [Related]
17. Low molecular weight dextran therapy for scleroderma. Effects of dextran 40 on blood flow and capillary filtration coefficient in scleroderma. Wong WH; Freedman RI; Raben SF; Schwartz S; Levan NE Arch Dermatol; 1974 Sep; 110(3):419-22. PubMed ID: 4451390 [No Abstract] [Full Text] [Related]
18. [Effect of rheopolyglucin on microcirculation function in systemic scleroderma]. Balabanova RM; Guseva NG; Apenysheva NP; Oskilko TG; Anikina NV Revmatologiia (Mosk); 1983; (3):26-8. PubMed ID: 6196831 [No Abstract] [Full Text] [Related]
19. Medical grand rounds from the University of Alabama Medical Center. South Med J; 1966 Nov; 59(11):1320-6. PubMed ID: 4959332 [No Abstract] [Full Text] [Related]
20. [Dextran of low molecular weight (rheomacrodex) in the treatment of retinal circulatory disorders]. Antoine F; Pierre I; Martinelle F Bull Soc Ophtalmol Fr; 1967 Dec; 67(12):1156-63. PubMed ID: 5621636 [No Abstract] [Full Text] [Related] [Next] [New Search]